Chapter 2: PTSD Assessment and Screening Tools

Accurate assessment forms the foundation of evidence-based PTSD treatment. Diagnostic precision ensures that individuals receive appropriate interventions matched to their specific symptom profiles, while standardized measurement enables objective tracking of treatment progress and outcomes. The WIA-MENTAL-006 standard establishes comprehensive specifications for digitizing evidence-based PTSD assessment instruments, ensuring that digital implementations maintain the psychometric properties, clinical validity, and standardization that make these tools valuable in clinical practice. This chapter examines the primary assessment instruments used in PTSD evaluation, their theoretical foundations, administration protocols, scoring procedures, and clinical interpretation guidelines.

PTSD assessment serves multiple critical functions throughout the treatment continuum. Initial screening identifies individuals who may benefit from comprehensive diagnostic evaluation, enabling efficient triage in primary care, emergency departments, and community settings where universal comprehensive assessment proves impractical. Diagnostic assessment establishes whether individuals meet full diagnostic criteria, informs differential diagnosis when symptoms overlap with other conditions, and provides baseline symptom severity measurement. Ongoing assessment during treatment quantifies symptom change, identifies treatment non-responders who may benefit from intervention modifications, and provides objective evidence of treatment effectiveness. Post-treatment assessment documents outcomes, informs decisions about treatment completion versus continuation, and establishes baselines for monitoring potential relapse.

The gold standard PTSD assessment approach combines clinician-administered structured interviews with patient self-report measures. Clinician-administered interviews enable skilled interviewers to clarify ambiguous responses, probe symptom details, distinguish PTSD symptoms from those of comorbid conditions, and make nuanced clinical judgments about symptom severity and functional impairment. Self-report measures offer efficiency advantages, eliminate interviewer variability, reduce assessment costs, and enable frequent repeated measurement during treatment. The WIA-MENTAL-006 standard supports digital implementation of both assessment modalities while preserving their unique strengths and addressing modality-specific implementation challenges.

PTSD Checklist for DSM-5 (PCL-5)

The PTSD Checklist for DSM-5 (PCL-5) represents the most widely used self-report measure of PTSD symptoms. Developed by the National Center for PTSD, the PCL-5 contains 20 items corresponding directly to the DSM-5 diagnostic criteria for PTSD. Respondents rate how much they have been bothered by each symptom during the past month using a 5-point Likert scale ranging from 0 (not at all) to 4 (extremely). Total scores range from 0 to 80, with higher scores indicating greater symptom severity. The PCL-5 demonstrates excellent psychometric properties, including strong internal consistency (alpha coefficients typically exceeding 0.90), test-retest reliability, and convergent validity with other PTSD measures.

The PCL-5 items are organized according to the DSM-5 symptom clusters: five items assess Criterion B intrusion symptoms (items 1-5), two items assess Criterion C avoidance symptoms (items 6-7), seven items assess Criterion D negative alterations in cognitions and mood (items 8-14), and six items assess Criterion E alterations in arousal and reactivity (items 15-20). This structure enables calculation of both total severity scores and cluster-specific subscale scores, facilitating identification of predominant symptom patterns that may inform treatment planning. For example, patients with particularly elevated avoidance subscale scores may benefit from exposure-based interventions, while those with prominent negative cognition subscale scores might respond well to cognitive restructuring approaches.

PCL-5 scoring and interpretation follow established guidelines developed through extensive psychometric research. For screening purposes, a provisional PTSD diagnosis can be made by treating each item rated as 2 (moderately) or higher as a symptom endorsement, then determining whether the endorsement pattern meets DSM-5 diagnostic criteria: at least 1 Criterion B item, 1 Criterion C item, 2 Criterion D items, and 2 Criterion E items. For symptom severity assessment, total scores are summed, with research suggesting that scores of 31-33 or higher indicate probable PTSD diagnosis with optimal balance of sensitivity and specificity, though the appropriate cut score varies somewhat depending on the population and clinical setting.

Table 2.1: PCL-5 Symptom Clusters and Item Mapping
DSM-5 Criterion	Symptom Cluster	PCL-5 Items	Number of Items	Score Range
Criterion B	Intrusion Symptoms	1-5	5	0-20
Criterion C	Avoidance	6-7	2	0-8
Criterion D	Negative Alterations in Cognitions and Mood	8-14	7	0-28
Criterion E	Alterations in Arousal and Reactivity	15-20	6	0-24
Total Score		1-20	20	0-80

Digital implementation of the PCL-5 must preserve several critical features ensuring clinical validity. The standardized instructions must be presented exactly as written in the official measure, as modifications can affect response patterns and invalidate comparison to normative data. The response scale must maintain the specific 0-4 anchoring descriptors (not at all, a little bit, moderately, quite a bit, extremely). Items must be presented in standard order without randomization, as some research suggests item sequence effects influence responses. The time frame ("in the past month") must be clearly specified and enforced through validation rules preventing completion by individuals attempting to rate different time periods.

{
  "type": "PCL5Assessment",
  "version": "1.0",
  "standard": "WIA-MENTAL-006",
  "assessment": {
    "instrumentId": "PCL-5",
    "administrationDate": "2025-12-27T14:30:00Z",
    "patientId": "encrypted_hash_value",
    "timeframeDescription": "past_month",
    "responses": [
      {"item": 1, "response": 3, "text": "Repeated, disturbing, and unwanted memories"},
      {"item": 2, "response": 4, "text": "Repeated, disturbing dreams"},
      {"item": 3, "response": 2, "text": "Suddenly feeling or acting as if traumatic event were actually happening again"},
      {"item": 4, "response": 4, "text": "Feeling very upset when reminded of the traumatic event"},
      {"item": 5, "response": 3, "text": "Having strong physical reactions when reminded"},
      {"item": 6, "response": 4, "text": "Avoiding memories, thoughts, or feelings related to the traumatic event"},
      {"item": 7, "response": 4, "text": "Avoiding external reminders of the traumatic event"},
      {"item": 8, "response": 3, "text": "Trouble remembering important parts of the traumatic event"},
      {"item": 9, "response": 4, "text": "Having strong negative beliefs about yourself, other people, or the world"},
      {"item": 10, "response": 3, "text": "Blaming yourself or someone else for the traumatic event or what happened after"},
      {"item": 11, "response": 4, "text": "Having strong negative feelings such as fear, horror, anger, guilt, or shame"},
      {"item": 12, "response": 2, "text": "Loss of interest in activities you used to enjoy"},
      {"item": 13, "response": 3, "text": "Feeling distant or cut off from other people"},
      {"item": 14, "response": 3, "text": "Trouble experiencing positive feelings"},
      {"item": 15, "response": 4, "text": "Irritable behavior, angry outbursts, or acting aggressively"},
      {"item": 16, "response": 3, "text": "Taking too many risks or doing things that could cause you harm"},
      {"item": 17, "response": 4, "text": "Being super-alert or watchful or on guard"},
      {"item": 18, "response": 4, "text": "Feeling jumpy or easily startled"},
      {"item": 19, "response": 3, "text": "Having difficulty concentrating"},
      {"item": 20, "response": 3, "text": "Trouble falling or staying asleep"}
    ],
    "scoring": {
      "totalScore": 67,
      "severity": "severe",
      "criterionB": 16,
      "criterionC": 8,
      "criterionD": 22,
      "criterionE": 21,
      "provisionalDiagnosis": true,
      "cutoffMethod": "total_score",
      "cutoffValue": 33,
      "meetsThreshold": true
    },
    "metadata": {
      "completionTime": 387,
      "deviceType": "mobile",
      "assistanceProvided": false
    }
  }
}

Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)

The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) represents the gold standard structured interview for PTSD diagnosis and symptom severity assessment. Developed by the National Center for PTSD, the CAPS-5 is a 30-item structured interview corresponding to the DSM-5 criteria for PTSD. Unlike self-report measures, the CAPS-5 requires administration by trained clinicians who can probe symptom descriptions, clarify ambiguous responses, distinguish trauma-related symptoms from those better explained by other conditions, and make informed severity ratings based on comprehensive clinical judgment. Administration typically requires 45-60 minutes, making it more resource-intensive than self-report measures but providing superior diagnostic accuracy.

The CAPS-5 assesses the 20 DSM-5 PTSD symptoms along with additional items evaluating onset and duration of symptoms, subjective distress, functional impairment, overall symptom severity, and global improvement since a previous CAPS administration. For each symptom, interviewers query both frequency and intensity, then combine these dimensions into a single severity rating ranging from 0 (absent) to 4 (extreme/incapacitating). The structured interview protocol provides specific prompts ensuring consistent administration across interviewers, though skilled interviewers can flexibly adapt questioning to optimize patient understanding while maintaining standardization.

CAPS-5 scoring enables both categorical diagnosis and dimensional severity assessment. For diagnostic purposes, a symptom is considered present if rated 2 (moderate) or higher, and diagnosis requires the symptom pattern meets DSM-5 criteria: at least 1 Criterion B symptom, 1 Criterion C symptom, 2 Criterion D symptoms, and 2 Criterion E symptoms, plus Criteria F (duration > 1 month), G (functional impairment), and H (not due to substances or medical conditions). For severity assessment, total symptom severity scores range from 0-80, with research suggesting the following severity ranges: 0-19 (asymptomatic/few symptoms), 20-39 (mild PTSD/subthreshold), 40-59 (moderate PTSD/threshold), and 60-80 (severe PTSD/extreme).

Table 2.2: CAPS-5 Severity Rating Descriptors
Rating	Severity Level	Frequency	Intensity	Clinical Example
0	Absent	None	None	No evidence of symptom
1	Mild/Subthreshold	Little/Once or twice	Minimal distress	Occasional intrusive thoughts with minimal distress
2	Moderate/Threshold	Some/Once or twice per week	Clearly present, definite distress	Weekly nightmares causing sleep disruption
3	Severe/Markedly Elevated	Much/3-4 times per week	Pronounced, considerable distress	Daily flashbacks significantly impairing functioning
4	Extreme/Incapacitating	Most/Daily or almost daily	Overwhelming, incapacitating	Constant hypervigilance preventing normal activities

Impact of Event Scale - Revised (IES-R)

The Impact of Event Scale - Revised (IES-R) is a widely used 22-item self-report measure assessing subjective distress caused by traumatic events. While developed before DSM-5 and not fully aligned with current diagnostic criteria, the IES-R remains valuable for measuring trauma-related distress, tracking symptom change during treatment, and screening for probable PTSD in research and clinical settings. The measure includes three subscales: intrusion (8 items assessing intrusive thoughts, nightmares, and flashbacks), avoidance (8 items assessing efforts to avoid trauma reminders), and hyperarousal (6 items assessing heightened physiological activation, irritability, and concentration difficulties).

Respondents rate how distressing each symptom has been during the past seven days using a 5-point scale: 0 (not at all), 1 (a little bit), 2 (moderately), 3 (quite a bit), and 4 (extremely). Total scores range from 0-88, with higher scores indicating greater distress. Research suggests that total scores above 24 indicate clinical concern warranting further assessment, scores above 33 represent probable PTSD diagnosis, and scores above 37 indicate severe PTSD symptomatology. The shorter time frame (past week rather than past month) makes the IES-R particularly useful for frequent repeated measurement during active treatment, enabling session-by-session tracking of symptom fluctuations.

Digital implementation of the IES-R requires attention to the event-specific nature of the measure. Unlike the PCL-5 which assesses symptoms related to any traumatic experience, the IES-R asks respondents to identify a specific traumatic event and rate symptoms specifically related to that event. The digital system must prompt users to specify the index trauma before presenting symptom items, maintain this trauma reference throughout the assessment, and track which trauma each assessment addresses to enable meaningful longitudinal comparison. For individuals with multiple traumas, separate IES-R administrations may assess different traumatic events, with the system clearly labeling which trauma each assessment references.

Patient Health Questionnaire-9 (PHQ-9)

The Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-report measure assessing depression severity based on DSM-5 diagnostic criteria for major depressive disorder. While not PTSD-specific, the PHQ-9 is essential in comprehensive PTSD assessment because depression represents the most common comorbid condition with PTSD, affecting 50-60% of individuals with PTSD diagnoses. Comorbid depression affects treatment planning, prognosis, and functional outcomes, making routine depression screening a critical component of evidence-based PTSD care. The PHQ-9 demonstrates excellent psychometric properties, requires only 2-3 minutes to complete, and is freely available without licensing fees.

The PHQ-9 items assess the nine DSM-5 criterion symptoms for major depressive disorder: anhedonia, depressed mood, sleep disturbance, fatigue, appetite changes, worthlessness/guilt, concentration difficulties, psychomotor changes, and suicidal ideation. Respondents rate how often they have been bothered by each symptom during the past two weeks using a 4-point scale: 0 (not at all), 1 (several days), 2 (more than half the days), and 3 (nearly every day). Total scores range from 0-27, with established severity categories: minimal (0-4), mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20-27) depression. Scores of 10 or higher indicate clinically significant depression warranting treatment consideration.

Item 9 of the PHQ-9 specifically assesses suicidal ideation, asking about thoughts of being better off dead or hurting oneself. Any endorsement of this item (score ≥ 1) requires immediate clinical follow-up regardless of total PHQ-9 score. Digital implementations must include automated flagging systems that immediately alert clinical staff when suicidal ideation is endorsed, trigger emergency contact protocols, and prevent completion of the assessment without clinical review. The WIA-MENTAL-006 standard specifies required safety protocols for managing suicidal ideation disclosures in digital mental health systems, ensuring patient safety while maintaining appropriate confidentiality boundaries.

Table 2.3: Comorbidity Assessment Battery
Instrument	Target Condition	Items	Time Frame	Clinical Cutoff	Severity Ranges
PHQ-9	Depression	9	Past 2 weeks	≥10	0-4 minimal, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe
GAD-7	Anxiety	7	Past 2 weeks	≥10	0-4 minimal, 5-9 mild, 10-14 moderate, 15-21 severe
PC-PTSD-5	PTSD Screening	5	Past month	≥3	Binary screening (positive ≥3)
AUDIT-C	Alcohol Use	3	Past year	≥4 (men), ≥3 (women)	0-3 low risk, 4-12 hazardous/harmful use
DAST-10	Drug Use	10	Past year	≥3	0-2 low, 3-5 moderate, 6-8 substantial, 9-10 severe
WHODAS 2.0	Functional Impairment	12/36	Past 30 days	Variable by domain	Domain-specific and total disability scores

Digital Assessment Implementation Requirements

The WIA-MENTAL-006 standard establishes detailed technical specifications ensuring digital assessment implementations maintain the clinical validity and psychometric integrity of validated instruments. Version control requirements mandate that digital systems clearly identify which version of each instrument is being administered, as instruments undergo periodic revisions that can affect score interpretation and normative comparisons. The system must prevent mixing items from different versions and maintain complete audit trails documenting which instrument version was used for each administration, enabling appropriate interpretation even as instruments evolve.

Presentation fidelity requirements ensure digital implementations preserve the exact wording, response options, and formatting of validated instruments. Unauthorized modifications—even seemingly minor changes like rewording items for "clarity" or reordering response options—can invalidate psychometric properties and prevent comparison to normative data. The standard requires digital implementations to obtain proper licensing from instrument developers, display copyright notices as specified in licensing agreements, and implement technical controls preventing unauthorized modifications to validated instruments. Regular validation testing comparing digital implementations against paper-and-pencil versions ensures equivalence.

Data quality assurance features must detect and address common response validity threats. Missing data detection prevents partial completion without explicit acknowledgment, distinguishing intentional item omission (legitimate in some contexts) from accidental skipping. Response pattern analysis flags straight-lining (identical responses across all items), rapid completion suggesting insufficient attention, and logically inconsistent response patterns. However, automated validity checks must be calibrated carefully to avoid false positives that frustrate legitimate respondents or introduce bias against individuals with severe symptoms who may legitimately endorse high severity across many items.

Adaptive Assessment Considerations: While the WIA-MENTAL-006 standard currently focuses on fixed-length instruments, emerging computerized adaptive testing (CAT) approaches offer potential advantages including reduced respondent burden and enhanced precision. CAT algorithms adaptively select items based on previous responses, potentially achieving equivalent measurement precision with fewer items. However, CAT implementations require extensive psychometric validation, item response theory modeling, and careful clinical validation before clinical deployment.

弘益人間

Benefit All Humanity

Accurate assessment serves humanity by ensuring individuals receive appropriate care matched to their specific needs. Digital assessment tools, implemented with rigorous attention to psychometric validity and clinical utility, can democratize access to high-quality evaluation previously available only in specialized settings.

Chapter Summary

Key Takeaways:

The PCL-5 represents the gold standard self-report PTSD measure with 20 items directly mapping to DSM-5 criteria, providing both categorical diagnostic screening and dimensional severity assessment with total scores ranging from 0-80 and clinical cutoffs typically set at 31-33.
The CAPS-5 structured interview provides superior diagnostic accuracy through trained clinician administration, enabling nuanced symptom assessment, differential diagnosis, and severity ratings based on combined frequency and intensity dimensions rated from 0 (absent) to 4 (extreme/incapacitating).
Comprehensive PTSD assessment requires evaluation of common comorbidities including depression (PHQ-9), generalized anxiety (GAD-7), substance use (AUDIT-C, DAST-10), and functional impairment (WHODAS 2.0), as these conditions affect treatment planning, prognosis, and outcomes.
Digital assessment implementation must preserve exact instrument wording, response options, and administration procedures to maintain psychometric validity, requiring proper licensing, version control, presentation fidelity verification, and equivalence testing against paper-and-pencil versions.
Safety protocols for digital assessment include immediate flagging and clinical review of suicidal ideation endorsements, crisis resource provision, and emergency contact procedures, with the WIA-MENTAL-006 standard establishing specific technical requirements ensuring patient safety while maintaining appropriate confidentiality.

Review Questions

Compare the PCL-5 and CAPS-5 in terms of administration method, time requirements, diagnostic accuracy, and appropriate use cases. Under what circumstances would each instrument be preferred?
Explain the DSM-5 symptom cluster structure and how it maps to the PCL-5 items. Why is cluster-specific scoring clinically useful beyond total severity scores?
Describe the CAPS-5 severity rating system. How do trained interviewers combine frequency and intensity dimensions to derive severity ratings, and why does this approach provide advantages over simple self-report?
Why is routine depression screening essential in PTSD assessment? What specific clinical decisions might be influenced by comorbid depression detection?
Discuss the critical importance of presentation fidelity in digital assessment implementation. Provide examples of seemingly minor modifications that could invalidate instrument psychometric properties.
What technical and clinical safeguards must digital assessment systems implement to appropriately manage suicidal ideation disclosures? How does the WIA-MENTAL-006 standard balance safety requirements with maintaining patient trust and engagement?

Looking Ahead

Chapter 3 examines Cognitive Processing Therapy (CPT), one of the most extensively validated PTSD treatments. We will explore the theoretical foundations of CPT, session-by-session protocol structure, cognitive worksheets for identifying and challenging stuck points, impact statement procedures, and digital implementation requirements supporting therapist-guided CPT delivery through telehealth and hybrid treatment models.

← Previous Chapter Next Chapter →